CloudMD Software & Services Inc. (DOCRF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CloudMD Software & Services Inc. (DOCRF) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 38/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026CloudMD Software & Services Inc. (DOCRF) Gesundheitswesen & Pipeline-Uebersicht
CloudMD Software & Services Inc. is a North American healthcare technology company delivering digital health, clinic, and enterprise solutions. It operates through three segments, offering services like virtual care, electronic medical records, and mental health support. The company's focus is on integrating technology to enhance healthcare delivery and patient outcomes.
Investmentthese
CloudMD Software & Services Inc. presents a speculative investment opportunity within the healthcare technology sector. The company's diverse service offerings, spanning digital health, clinic services, and enterprise solutions, position it to capitalize on the growing demand for integrated healthcare solutions. However, the company's negative profit margin of -91.5% raises concerns about its profitability and financial sustainability. Key growth catalysts include the expansion of its digital health services and the integration of its various platforms. Investors should closely monitor the company's ability to improve its financial performance and achieve profitability. As of March 16, 2026, the company's market capitalization is $0.01 billion, and the P/E ratio is -0.14.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- CloudMD operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions.
- The company offers MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits.
- CloudMD provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores.
- The company's gross margin is 23.2%.
- CloudMD's market capitalization is $0.01 billion as of March 16, 2026.
Wettbewerber & Vergleichsunternehmen
Staerken
- Comprehensive suite of healthcare services.
- Integrated technology platform.
- Established network of clinics and pharmacies.
- Experienced management team.
Schwaechen
- Negative profit margin.
- Limited brand recognition.
- High reliance on acquisitions for growth.
- OTC market listing.
Katalysatoren
- Ongoing: Expansion of digital health services and telemedicine capabilities.
- Ongoing: Integration of healthcare platforms to create a seamless patient experience.
- Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
- Ongoing: Focus on mental health solutions to capitalize on growing demand.
- Upcoming: Potential expansion into new geographic markets within the next 3-5 years.
Risiken
- Ongoing: Intense competition in the healthcare technology industry.
- Potential: Regulatory changes impacting the healthcare sector.
- Potential: Economic downturn affecting healthcare spending.
- Potential: Technological obsolescence of existing platforms.
- Ongoing: Negative profit margin and financial sustainability concerns.
Wachstumschancen
- Expansion of Digital Health Services: CloudMD can capitalize on the growing demand for virtual care and remote patient monitoring by expanding its digital health services. The telemedicine market, estimated to reach $460 billion by 2030, presents a significant opportunity for CloudMD to increase its market share. By investing in its MyHealthAccess platform and telemedicine capabilities, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
- Integration of Healthcare Platforms: CloudMD can drive growth by integrating its various healthcare platforms, such as MyHealthAccess, Health and Wellness, and iMD platform, to create a seamless and comprehensive healthcare experience for patients and providers. This integration can improve patient engagement, enhance clinical outcomes, and generate valuable data insights. The integrated healthcare market is expected to grow at a CAGR of 12% over the next five years. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: CloudMD can pursue strategic partnerships and acquisitions to expand its service offerings, geographic reach, and customer base. By partnering with other healthcare providers, technology companies, and pharmaceutical companies, CloudMD can create synergistic relationships that drive growth and innovation. The company can also acquire complementary businesses to expand its market presence and gain access to new technologies. Timeline: Ongoing.
- Focus on Mental Health Solutions: CloudMD can capitalize on the growing awareness of mental health and the increasing demand for mental health services by focusing on its mental health solutions. The mental health market is estimated to reach $537.96 billion by 2030. By investing in its mental health support services and expanding its network of mental health professionals, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
- Expansion into New Geographic Markets: CloudMD can expand its operations into new geographic markets, such as the United States and Europe, to increase its customer base and revenue. The global healthcare market is expected to grow at a CAGR of 5% over the next five years. By establishing a presence in new markets, CloudMD can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Upcoming: Within the next 3-5 years.
Chancen
- Expansion of digital health services.
- Strategic partnerships and acquisitions.
- Focus on mental health solutions.
- Expansion into new geographic markets.
Risiken
- Intense competition.
- Regulatory changes.
- Economic downturn.
- Technological obsolescence.
Wettbewerbsvorteile
- Integrated platform offering a comprehensive suite of healthcare services.
- Established network of clinics and pharmacies.
- Proprietary technology platforms like MyHealthAccess and Health and Wellness.
- Strong relationships with healthcare providers and employers.
Ueber DOCRF
CloudMD Software & Services Inc., established in 2013 and formerly known as Premier Health Group Inc., rebranded in February 2020 to reflect its focus on cloud-based healthcare solutions. Headquartered in Vancouver, Canada, CloudMD operates as a healthcare technology company in North America. The company is structured into three primary segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. These segments provide a comprehensive suite of services, including mental health support, healthcare navigation, rehabilitation and assessments, education, absence management, and occupational health. CloudMD also offers billing and electronic medical records solutions, along with MyHealthAccess, a patient portal for online appointment booking and virtual care visits. Additionally, the company provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores. Other offerings include the iMD platform for educational resources, telemedicine services, and VisionPros, an online vision care platform. CloudMD operates a network of hybrid medical and rehabilitation clinics, as well as medical clinics for family practice and patient care. Its pharmacies retail prescription drugs, over-the-counter drugs, and other front store items. The company also provides patient support programs for disease management and clinical treatment outcomes, along with pharmaceutical logistic services.
Was das Unternehmen tut
- Provides enterprise health solutions, including mental health support and healthcare navigation.
- Offers rehabilitation and assessments, education, absence management, and occupational health services.
- Provides billing and electronic medical records solutions.
- Offers MyHealthAccess, a patient portal for online appointment booking and virtual care visits.
- Provides the Health and Wellness platform for real-time data analysis and risk score computation.
- Offers the iMD platform for peer-reviewed educational resources.
- Provides telemedicine services.
- Operates VisionPros, an online vision care platform.
Geschaeftsmodell
- Subscription fees for digital health platforms like MyHealthAccess and Health and Wellness.
- Revenue from clinic services and pharmacies, including prescription drugs and over-the-counter sales.
- Fees for enterprise health solutions, such as mental health support and healthcare navigation.
- Revenue from telemedicine services and virtual care visits.
Branchenkontext
CloudMD operates within the rapidly evolving healthcare technology industry, which is experiencing significant growth due to increasing demand for digital health solutions and integrated healthcare services. The market is characterized by intense competition, with companies vying to provide innovative solutions that improve patient outcomes and reduce healthcare costs. CloudMD's focus on integrating digital health services, clinic services, and enterprise solutions positions it to capitalize on the trend towards more holistic and patient-centric care. Competitors include companies like BCBCF (WELL Health Technologies Corp.), CLSH (Clarus Therapeutics Holdings, Inc.), CRBKF (CareRx Corporation), FFLWF (Firefly Health, Inc.), and HBCNF (Helius Medical Technologies, Inc.).
Wichtige Kunden
- Employers seeking enterprise health solutions for their employees.
- Patients seeking virtual care and online appointment booking.
- Healthcare providers using billing and electronic medical records solutions.
- Individuals seeking mental health support and healthcare navigation services.
Finanzdaten
Chart & Info
CloudMD Software & Services Inc. (DOCRF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer DOCRF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DOCRF.
Kursziele
Wall-Street-Kurszielanalyse fuer DOCRF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von DOCRF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Karen Adams
CEO
Karen Adams is the CEO of CloudMD Software & Services Inc. Her background includes extensive experience in the healthcare and technology sectors. She has held leadership positions in various companies, focusing on strategic growth, operational efficiency, and customer satisfaction. Her expertise spans across digital health solutions, healthcare services, and enterprise management. She is responsible for managing 224 employees.
Erfolgsbilanz: Under Karen Adams' leadership, CloudMD has focused on expanding its digital health offerings and integrating its various platforms. Key milestones include the acquisition of several companies to broaden its service portfolio and geographic reach. She has also overseen the implementation of new technologies to improve patient outcomes and enhance operational efficiency. Her tenure has been marked by a focus on innovation and strategic growth.
DOCRF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that CloudMD Software & Services Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is generally associated with higher risk due to the potential for less transparency and liquidity.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Lower liquidity compared to major exchanges.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their track record.
- Review the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Understand the risks associated with OTC trading.
- Company has been in operation since 2013.
- Operates in the healthcare technology sector, which is experiencing growth.
- Offers a range of digital health solutions and services.
- Has a network of clinics and pharmacies.
- Led by CEO Karen Adams.
DOCRF Healthcare Aktien-FAQ
What are the key factors to evaluate for DOCRF?
CloudMD Software & Services Inc. (DOCRF) currently holds an AI score of 38/100, indicating low score. Key strength: Comprehensive suite of healthcare services.. Primary risk to monitor: Ongoing: Intense competition in the healthcare technology industry.. This is not financial advice.
How frequently does DOCRF data refresh on this page?
DOCRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DOCRF's recent stock price performance?
Recent price movement in CloudMD Software & Services Inc. (DOCRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive suite of healthcare services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DOCRF overvalued or undervalued right now?
Determining whether CloudMD Software & Services Inc. (DOCRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DOCRF?
Before investing in CloudMD Software & Services Inc. (DOCRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding DOCRF to a portfolio?
Potential reasons to consider CloudMD Software & Services Inc. (DOCRF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive suite of healthcare services.. Additionally: Integrated technology platform.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of DOCRF?
Yes, most major brokerages offer fractional shares of CloudMD Software & Services Inc. (DOCRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DOCRF's earnings and financial reports?
CloudMD Software & Services Inc. (DOCRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DOCRF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.